Clinical evidence: GLP-1 medications in lupus patients The research specifically examining GLP-1 receptor agonists in lupus patients is limited but growing
Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Moller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Nunez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Shah SJ
This demonstrates that GLP-1 medications address an underlying biological condition rather than simply reducing appetite through behavioral modification
The way Contrave works for weight loss is not entirely understood
Members who engage with Nooms GLP-1 Companion achieve success, as measured by 10% weight loss by month 4, at twice the rate as those who are not engaged in the companion app
GLP-1 is a naturally occurring peptide that plays a major role in appetite regulation and blood sugar control
